` Comparison: 2315, PNEXF - Alpha Spread

B
2315
vs
PNEXF

Over the past 12 months, Biocytogen Pharmaceuticals Beijing Co Ltd has significantly outperformed PNEXF, delivering a return of +207% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
2315
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

B
Intrinsic Value
14.76 HKD
Overvaluation 43%
Intrinsic Value
Price
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
25.76 HKD
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
2315, PNEXF

2315
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
Biocytogen Pharmaceuticals Beijing Co Ltd
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
2315, PNEXF

2315
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Biocytogen Pharmaceuticals Beijing Co Ltd
77.1%
PNEXF
0%

Operating Margin

Biocytogen Pharmaceuticals Beijing Co Ltd
18.1%
PNEXF
-17 526.7%

Net Margin

Biocytogen Pharmaceuticals Beijing Co Ltd
11.1%
PNEXF
-21 040%

FCF Margin

Biocytogen Pharmaceuticals Beijing Co Ltd
28.4%
PNEXF
-15 953.3%

ROE

Biocytogen Pharmaceuticals Beijing Co Ltd
16.2%
PNEXF
114.6%

ROA

Biocytogen Pharmaceuticals Beijing Co Ltd
5.4%
PNEXF
-391.1%

ROIC

Biocytogen Pharmaceuticals Beijing Co Ltd
10.1%
PNEXF
3 092.9%

ROCE

Biocytogen Pharmaceuticals Beijing Co Ltd
11.1%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
2315, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
2315, PNEXF

Loading
2315
PNEXF
Difference
www.alphaspread.com

Performance By Year
2315, PNEXF

Loading
2315
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 2315 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account